In 2023, the Global Cancer Monoclonal Antibodies market reached a value of USD 56.7 billion. By 2031, it is expected to grow to USD 107.9 billion, reflecting a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2024 to 2031. The "Global Cancer Monoclonal Antibodies Market" report presents a thorough analysis of market dynamics, recent developments, and business strategy...